100 MIgraine drugs, A to Z: lamotrigine

July 7, 2020

Lamotrigine (Lamictal) is an epilepsy drug that is also approved as a mood stabilizer in bipolar disorders. Its exact mechanism of action is not well understood.

There are no good controlled trials of lamotrigine in migraines, but an open long-term study by European neurologists suggests that 100 mg of lamotrigine is effective not only in reducing the frequency of migraines but also in reducing the frequency and the duration of visual auras. There are also case reports of lamotrigine relieving complicated auras with visual and sensory symptoms.

The main side effects of lamotrigine are dizziness, drowsiness, upset stomach, and rash. The rash can be serious and in very rare cases fatal (Stevens-Johnson syndrome), but it could be avoided by starting with a very low dose (25 mg) and increasing it by 25 mg every two weeks. For epilepsy, the dose goes up to as high as 600 mg a day.

Written by
Alexander Mauskop, MD
Continue reading
March 26, 2026
Alternative Therapies
Lidocaine-Based Treatments Offer Another Option for Severe Migraines
This post explains how lidocaine, beyond its traditional use as a local anesthetic, can be given by IV or directly into the middle meningeal artery to help break severe, treatment-resistant migraines, with early studies showing promising relief and generally mild, manageable side effects.
Read article
February 16, 2026
News
Potential big news for the 40 million Americans with migraine.
It is long overue to make triptans available without a prescription, like in the rest of the world.
Read article